These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44 related articles for article (PubMed ID: 2235818)
1. Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated rat. Frezza EE; Gerunda GE; Plebani M; Galligioni A; Giacomini A; Neri D; Faccioli AM; Tiribelli C Dig Dis Sci; 1993 Jul; 38(7):1291-6. PubMed ID: 8325189 [TBL] [Abstract][Full Text] [Related]
2. [Bile acids in the therapy of chronic liver diseases]. Sperandeo M; Varriale A; Sperandeo G; Carughi S; Lucentini L Recenti Prog Med; 1993 Mar; 84(3):225-30. PubMed ID: 8465104 [TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid therapy in chronic active hepatitis. Bateson MC Postgrad Med J; 1990 Sep; 66(779):781-3. PubMed ID: 2235818 [TBL] [Abstract][Full Text] [Related]
4. Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal. Stellon AJ; Keating JJ; Johnson PJ; McFarlane IG; Williams R Hepatology; 1988; 8(4):781-4. PubMed ID: 3292363 [TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic liver disease with ursodeoxycholic acid. Guslandi M J Int Med Res; 1990; 18(6):497-505. PubMed ID: 2292332 [TBL] [Abstract][Full Text] [Related]
6. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904 [TBL] [Abstract][Full Text] [Related]
7. Randomised controlled trial of azathioprine withdrawal in autoimmune chronic active hepatitis. Stellon AJ; Hegarty JE; Portmann B; Williams R Lancet; 1985 Mar; 1(8430):668-70. PubMed ID: 2858619 [TBL] [Abstract][Full Text] [Related]
8. Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study. Crosignani A; Battezzati PM; Setchell KD; Camisasca M; Bertolini E; Roda A; Zuin M; Podda M Hepatology; 1991 Feb; 13(2):339-44. PubMed ID: 1671665 [TBL] [Abstract][Full Text] [Related]
9. Effect of chenodeoxycholic and ursodeoxycholic acids on isolated adult human hepatocytes. Miyazaki K; Nakayama F; Koga A Dig Dis Sci; 1984 Dec; 29(12):1123-30. PubMed ID: 6499631 [TBL] [Abstract][Full Text] [Related]
11. Norethisterone jaundice in two sisters. Somayaji BN; Paton A; Price JH; Harris AW; Flewett TH Br Med J; 1968 May; 2(5600):281-3. PubMed ID: 4296504 [No Abstract] [Full Text] [Related]
12. Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study. Leuschner U; Leuschner M; Sieratzki J; Kurtz W; Hübner K Dig Dis Sci; 1985 Jul; 30(7):642-9. PubMed ID: 4006646 [TBL] [Abstract][Full Text] [Related]
13. Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis. Czaja AJ; Beaver SJ; Shiels MT Gastroenterology; 1987 Jan; 92(1):215-9. PubMed ID: 3781190 [TBL] [Abstract][Full Text] [Related]
14. Bile acid metabolism in cirrhotic liver tissue--altered synthesis and impaired hepatic secretion. Akashi Y; Miyazaki H; Yanagisawa J; Nakayama F Clin Chim Acta; 1987 Sep; 168(2):199-206. PubMed ID: 3677416 [TBL] [Abstract][Full Text] [Related]